IPIX is on tract and doing all the can do and should do with great product potential IMO as far as products go.
Whether they make it or not depends on whose palms they grease along the way. Should they have enough connections on the good side of the FDA which means some in the world of big pharma are going to have to profit. Even then, it will be push and shove as other "favorites" are in the pipeline as well. So it will take partnerships with clout which doesn't come cheap. Long IPIX.
News 
Market Data 
Discover 
